NPPA Revises Ceiling Price Of 476 Scheduled Formulations, Details
New Delhi: In accordance with the price revision as per the annual wholesale price index increase of 12.1218%, through the recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of the 476 scheduled formulations under the Drug( Price Control) Order, 2013.
The list includes 6- Mercaptopurine, Abacavir, Acetazolamide, Actinomycin D, Acyclovir, Adenosine, Adrenaline, Allopurinol, Amiodarone, Amitriptyline, Amoxicillin, Ampicillin, Atorvastatin, Atropine, Azathioprine, Azithromycin, Baclofen, Bendamustine hydrochloride, Benzoyl peroxide, Bisacodyl, Bleomycin, Bortezomib, Buprenorphine, Caffeine, Capecitabine, Carbamazepine, Carboplatin, Carbimazole, Cefixime, Cefotaxime, Cefuroxime and others.
Earlier, the Medical Dialogue Team had reported that according to the NPPA notification, based on the Wholesale Price Index (WPI) data provided by the Office of the Economic Advisor, Department of Industry and Internal Trade, Ministry of Commerce and Industry, the annual change in the WPI works out to 12.1218% during the calendar year 2022 over the corresponding period in 2021.
In relation to the above, the pharma industry is going to see the highest ever annual increase in prices of essential medicines as the cost of such drugs including painkillers, anti-infectives, antibiotics are set to rise by more than 12 percent effective April 1, 2023.
Scheduled formulation means any formulation, included in the First Schedule whether referred to by generic versions or brand names (mainly products covered under the National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in the National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation.
"Ceiling Price" refers to a price fixed by the Government for Scheduled Formulations in accordance with the provisions of the drugs (prices control) order, 2013. Ceiling Price is the Maximum Price to Retailer (excluding Taxes, if any)for the given product.
The notice declared that in exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013, S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby has fixed the prices as specified in column (5) of the table herein below as ceiling prices exclusive of Goods and Services Tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
1 | 6- Mercaptopurine | Tablet 50mg | 1 Tablet | 5.25 | 194(E) | 11.01.2023 |
2 | Abacavir | Tablet 300 mg | 1 Tablet | 48.59 | 5938(E) | 19.12.2022 |
3 | Abacavir (A) +Lamivudine(B) | Tablet 600mg (A) +300mg (B) | 1 Tablet | 72.31 | 5938(E) | 19.12.2022 |
4 | Tablet 250mg | 1 Tablet | 4.05 | 87(E) | 06.01.2023 | |
5 | Actinomycin D | Powder for Injection 0.5mg | 1 Vial | 331.00 | 879(E) | 24.02.2023 |
6 | Acyclovir | Tablet 400mg | 1 Tablet | 13.65 | 87(E) | 06.01.2023 |
7 | Acyclovir | Tablet 200mg | 1 Tablet | 7.61 | 87(E) | 06.01.2023 |
8 | Acyclovir | Powder for Injection 250 mg | 1 Vial | 426.37 | 194(E) | 11.01.2023 |
9 | Acyclovir | Powder for Injection 500 mg | 1 Vial | 528.41 | 194(E) | 11.01.2023 |
10 | Acyclovir | Tablet 800mg | 1 Tablet | 37.66 | 195(E) | 11.01.2023 |
11 | Acyclovir | Ointment 3% | 1 GM | 11.67 | 879(E) | 24.02.2023 |
12 | Injection 3mg/mL | 1 ML | 92.84 | 194(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
13 | Adrenaline | Injection1mg/mL | 1 ML | 12.23 | 879(E) | 24.02.2023 |
14 | Allopurinol | Tablet 300mg | 1 Tablet | 5.62 | 5938(E) | 19.12.2022 |
15 | Allopurinol | Tablet 100mg | 1 Tablet | 1.89 | 87(E) | 06.01.2023 |
16 | Alprostadil | Injection 0.5mg/mL | 1 ML | 6106.41 | 879(E) | 24.02.2023 |
17 | Amiodarone | Tablet 200mg | 1 Tablet | 11.51 | 87(E) | 06.01.2023 |
18 | Amiodarone | Tablet 100mg | 1 Tablet | 6.14 | 87(E) | 06.01.2023 |
19 | Injection 50mg/mL | 1 ML | 21.13 | 194(E) | 11.01.2023 | |
20 | Amitriptyline | Tablet 50mg | 1 Tablet | 5.98 | 5938(E) | 19.12.2022 |
21 | Amitriptyline | Tablet 75mg | 1 Tablet | 5.44 | 89(E) | 06.01.2023 |
22 | Amitriptyline | Tablet 25mg | 1 Tablet | 2.48 | 89(E) | 06.01.2023 |
23 | Amitriptyline | Tablet 10mg | 1 Tablet | 2.38 | 194(E) | 11.01.2023 |
24 | Amlodipine | Tablet 2.5mg | 1 Tablet | 1.79 | 89(E) | 06.01.2023 |
25 | Amlodipine | Tablet 5mg | 1 Tablet | 2.50 | 5938(E) | 19.12.2022 |
26 | Amlodipine | Tablet 10mg | 1 Tablet | 5.44 | 89(E) | 06.01.2023 |
27 | Amoxicillin | Capsule 250mg | 1 Capsule | 2.44 | 194(E) | 11.01.2023 |
28 | Capsule 500mg | 1 Capsule | 7.35 | 484(E) | 02.02.2023 | |
29 | Amoxicillin (A) + Clavulanic acid (B) | Powder for Injection 1 g (A) +200mg (B) | 1 Vial | 140.64 | 87(E) | 06.01.2023 |
30 | Amoxicillin (A) + Clavulanic acid (B) | Powder for Injection 500mg (A) + 100mg (B) | 1 Vial | 101.33 | 194(E) | 11.01.2023 |
31 | Amoxicillin (A) + Clavulanic acid (B) | Dry Syrup 125mg (A) + 31.25 (B)/5mL(p) | 1 ML | 2.05 | 194(E) | 11.01.2023 |
32 | Amoxicillin (A) +Clavulanic acid (B) | Tablet 500 mg (A) + 125 mg (B) | 1 Tablet | 18.29 | 87(E) | 06.01.2023 |
33 | Amoxicillin (A) +Clavulanic acid (B) | Oral liquid 200 mg (A) + 28.5mg(B)/5 mL(p) | 1 ML | 2.01 | 484(E) | 02.02.2023 |
34 | Powder for Injection 500 mg | 1 Vial | 14.25 | 87(E) | 06.01.2023 | |
35 | Artemether (A) + Lumefantrine(B) | Tablet 40 mg (A) + 240 mg (B) | 1 Tablet | 18.04 | 194(E) | 11.01.2023 |
36 | Artemether (A) +Lumefantrine(B ) | Tablet 80mg(A)+480mg(B) | 1 Tablet | 25.50 | 5938(E) | 19.12.2022 |
37 | Artemether (A) | Tablet 20 mg (A) + | 1 Tablet | 12.64 | 5938(E) | 19.12.2022 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
+Lumefantrine(B ) | 120 mg (B) | |||||
38 | Artesunate | Powder for Injection 60 mg | 1 Vial | 244.71 | 194(E) | 11.01.2023 |
39 | Artesunate | Powder for Injection 120mg | 1 Vial | 454.40 | 194(E) | 11.01.2023 |
40 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | Combi pack (A+B) 1 Tablet 50mg (A) + 1Tablet (500mg + 25mg) (B) | 1 Combi Pack | 22.54 | 194(E) | 11.01.2023 |
41 | Atazanavir (A) +Ritonavir(B) | Tablet 300mg(A) + Tablet 100mg(B) | 1 Tablet | 99.82 | 87(E) | 06.01.2023 |
42 | Tablet 40mg | 1 Tablet | 19.29 | 89(E) | 06.01.2023 | |
43 | Atorvastatin | Tablet 20mg | 1 Tablet | 12.55 | 89(E) | 06.01.2023 |
44 | Atorvastatin | Tablet 10mg | 1 Tablet | 4.94 | 89(E) | 06.01.2023 |
45 | Atorvastatin | Tablet 80mg | 1 Tablet | 40.57 | 5939(E) | 19.12.2022 |
46 | Atropine | Drops 1% | 1 ML | 3.93 | 879(E) | 24.02.2023 |
47 | Atropine | Ointment 1% | 1 GM | 4.70 | 879(E) | 24.02.2023 |
48 | Atropine | Injection 0.6mg/mL | 1 ML | 4.57 | 879(E) | 24.02.2023 |
49 | Azathioprine | Tablet 50mg | 1 Tablet | 11.25 | 87(E) | 06.01.2023 |
50 | Powder for Injection 500mg | 1 Vial | 204.71 | 194(E) | 11.01.2023 | |
51 | Azithromycin | Tablet 250mg | 1 Tablet | 11.64 | 484(E) | 02.02.2023 |
52 | Azithromycin | Tablet 500mg | 1 Tablet | 23.56 | 484(E) | 02.02.2023 |
53 | Azithromycin | Oral liquid 200 mg/5 mL (p) | 1 ML | 3.40 | 484(E) | 02.02.2023 |
54 | Baclofen | Tablet 20mg | 1 Tablet | 16.28 | 5938(E) | 19.12.2022 |
55 | Baclofen | Tablet 10mg | 1 Tablet | 11.89 | 89(E) | 06.01.2023 |
56 | Baclofen | Tablet 5mg | 1 Tablet | 6.36 | 5938(E) | 19.12.2022 |
57 | Bendamustine hydrochloride | Injection 100 mg/vial | 1 Vial | 4946.53 | 195(E) | 11.01.2023 |
58 | Benzoyl peroxide | Gel 2.5 % | 1 GM | 3.62 | 879(E) | 24.02.2023 |
59 | Benzoyl peroxide | Gel 5 % | 1 GM | 7.97 | 879(E) | 24.02.2023 |
60 | Betamethasone valerate | Cream 0.05% | 1 GM | 0.67 | 879(E) | 24.02.2023 |
61 | Betamethasone valerate | Cream 0.1% | 1 GM | 1.04 | 879(E) | 24.02.2023 |
62 | Bicalutamide | Tablet 50mg | 1 Tablet | 43.30 | 5938(E) | 19.12.2022 |
63 | Bisacodyl | Tablet 5mg | 1 Tablet | 1.16 | 87(E) | 06.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
64 | Bisacodyl | Suppository 5mg | 1 Supposit ory | 9.97 | 484(E) | 02.02.2023 |
65 | Bleomycin | Powder for Injection 15units | 1 Vial | 677.37 | 194(E) | 11.01.2023 |
66 | Bortezomib | Powder for Injection 2mg | 1 Vial | 5260.20 | 194(E) | 11.01.2023 |
67 | Buprenorphine | Tablet (Sub- lingual)0.4mg | 1 Tablet | 9.42 | 88(E) | 06.01.2023 |
68 | Buprenorphine (A) +Naloxone (B) | Tablet (Sub-lingual) 2mg(A)+0.5mg(B) | 1 Tablet | 36.97 | 88(E) | 06.01.2023 |
69 | Buprenorphine (A) +Naloxone (B) | Tablet (Sub-lingual) 0.4mg(A)+0.1mg(B) | 1 Tablet | 11.81 | 88(E) | 06.01.2023 |
70 | Caffeine | Oral liquid 20 mg/mL | 1 ML | 245.67 | 194(E) | 11.01.2023 |
71 | Calcium folinate | Tablet 15mg | 1 Tablet | 47.53 | 879(E) | 24.02.2023 |
72 | Capecitabine | Tablet 500mg | 1 Tablet | 112.71 | 5938(E) | 19.12.2022 |
73 | Carbamazepine | Modified Release – Tablet 200mg | 1 Tablet | 2.39 | 5938(E) | 19.12.2022 |
74 | Carbamazepine | Modified Release – Tablet 400mg | 1 Tablet | 4.66 | 5938(E) | 19.12.2022 |
75 | Carbamazepine | Tablet 400mg | 1 Tablet | 3.55 | 5938(E) | 19.12.2022 |
76 | Carbamazepine | Tablet 200mg | 1 Tablet | 1.56 | 87(E) | 06.01.2023 |
77 | Carbamazepine | Oral liquid 100mg/5mL(p) | 1 ML | 0.31 | 194(E) | 11.01.2023 |
78 | Carbamazepine | Tablet 100mg | 1 Tablet | 1.06 | 484(E) | 02.02.2023 |
79 | Carbimazole | Tablet 10mg | 1 Tablet | 4.26 | 87(E) | 06.01.2023 |
80 | Carbimazole | Tablet 5mg | 1 Tablet | 2.18 | 87(E) | 06.01.2023 |
81 | Carbimazole | Tablet 20mg | 1 Tablet | 13.86 | 195(E) | 11.01.2023 |
82 | Carboplatin | Injection 10mg/mL | 1 ML | 59.06 | 879(E) | 24.02.2023 |
83 | Carboxymethyl cellulose | Drops 0.5% | 1 ML | 12.29 | 484(E) | 02.02.2023 |
84 | Carboxymethyl cellulose | Drops 1% | 1 ML | 16.58 | 484(E) | 02.02.2023 |
85 | Cefadroxil | Tablet 500mg | 1 Tablet | 4.47 | 5938(E) | 19.12.2022 |
86 | Cefadroxil | Oral liquid 125mg/5mL(p) | 1 ML | 0.68 | 194(E) | 11.01.2023 |
87 | Cefixime | Tablet 400mg | 1 Tablet | 22.09 | 5938(E) | 19.12.2022 |
88 | Cefixime | Tablet 200mg | 1 Tablet | 9.77 | 87(E) | 06.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
89 | Oral liquid 50 mg/5 mL (p) | 1 ML | 1.62 | 484(E) | 02.02.2023 | |
90 | Cefixime | Oral liquid 100mg/5mL(p) | 1 ML | 2.38 | 484(E) | 02.02.2023 |
91 | Cefotaxime | Powder for Injection 250 mg | 1 Vial | 17.71 | 87(E) | 06.01.2023 |
92 | Cefotaxime | Powder for Injection 500 mg | 1 Vial | 24.37 | 87(E) | 06.01.2023 |
93 | Cefotaxime | Powder for Injection 1000mg | 1 Vial | 39.96 | 87(E) | 06.01.2023 |
94 | Ceftazidime | Powder for Injection 1000mg | 1 Vial | 227.01 | 87(E) | 06.01.2023 |
95 | Ceftazidime | Powder for Injection 250 mg | 1 Vial | 79.06 | 484(E) | 02.02.2023 |
96 | Ceftriaxone | Powder for Injection 500 mg | 1 Vial | 50.27 | 87(E) | 06.01.2023 |
97 | Ceftriaxone | Powder for Injection 250 mg | 1 Vial | 28.34 | 87(E) | 06.01.2023 |
98 | Ceftriaxone | Powder for Injection 1000mg | 1 Vial | 62.38 | 87(E) | 06.01.2023 |
99 | Ceftriaxone | Powder for Injection 2000mg | 1 Vial | 138.11 | 87(E) | 06.01.2023 |
100 | Oralliquid 125mg/5mL(p) | 1 ML | 5.28 | 5939(E) | 19.12.2022 | |
101 | Cetirizine | Tablet 10mg | 1 Tablet | 1.88 | 194(E) | 11.01.2023 |
102 | Cetirizine | Oral liquid 5mg/5mL(p) | 1 ML | 0.66 | 484(E) | 02.02.2023 |
103 | Chloroquine | Tablet 150 mg | 1 Tablet | 1.16 | 194(E) | 11.01.2023 |
104 | Chloroquine | Oral liquid 50mg/5mL | 1 ML | 0.33 | 194(E) | 11.01.2023 |
105 | Cholecalciferol | Tablet 1000 IU | 1 Tablet | 4.30 | 5938(E) | 19.12.2022 |
106 | Cholecalciferol | Oral liquid 400 IU/mL | 1 ML | 2.61 | 194(E) | 11.01.2023 |
107 | Cholecalciferol | Solid oral dosage form 60000 IU Tablets | 1 Tablet | 22.50 | 484(E) | 02.02.2023 |
108 | Ciprofloxacin | Tablet 250mg | 1 tablet | 2.19 | 87(E) | 06.01.2023 |
109 | Ciprofloxacin | Tablet 500mg | 1 tablet | 4.24 | 87(E) | 06.01.2023 |
110 | Ciprofloxacin | Drops 0.3 % | 1 ML | 1.53 | 194(E) | 11.01.2023 |
111 | Ciprofloxacin | Injection 200mg/100mL | 1 ML | 0.20 | 194(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
112 | Ciprofloxacin | Ointment 0.3% | 1 GM | 1.28 | 879(E) | 24.02.2023 |
113 | Cisplatin | Injection 1mg/mL | 1 ML | 7.08 | 879(E) | 24.02.2023 |
114 | Clarithromycin | Tablet 250mg | 1 Tablet | 23.89 | 89(E) | 06.01.2023 |
115 | Clarithromycin | Tablet 500mg | 1 Tablet | 39.83 | 89(E) | 06.01.2023 |
116 | Clarithromycin | Oral liquid 125mg/5mL(p) | 1 ML | 4.60 | 194(E) | 11.01.2023 |
117 | Clindamycin | Capsule 150mg | 1 Capsule | 16.35 | 5938(E) | 19.12.2022 |
118 | Clindamycin | Capsule 300mg | 1 Capsule | 28.36 | 5938(E) | 19.12.2022 |
119 | Clindamycin | Tablet 300mg | 1 Tablet | 18.97 | 194(E) | 11.01.2023 |
120 | Clobazam | Tablet 5mg | 1 Tablet | 5.72 | 89(E) | 06.01.2023 |
121 | Clobazam | Tablet 10mg | 1 Tablet | 9.84 | 89(E) | 06.01.2023 |
122 | Clomiphenecitrat e | Tablet 100 mg | 1 Tablet | 13.94 | 194(E) | 11.01.2023 |
123 | Clomiphenecitrat e | Tablet 50mg | 1 Tablet | 8.83 | 194(E) | 11.01.2023 |
124 | Clonazepam | Tablet 0.25mg | 1 Tablet | 2.01 | 87(E) | 06.01.2023 |
125 | Clonazepam | Tablet 0.5mg | 1 Tablet | 3.45 | 87(E) | 06.01.2023 |
126 | Clonazepam | Tablet 1mg | 1 Tablet | 4.76 | 87(E) | 06.01.2023 |
127 | Clopidogrel | Tablet 75mg | 1 Tablet | 6.66 | 87(E) | 06.01.2023 |
128 | Clopidogrel | Tablet 150 mg | 1 Tablet | 20.48 | 195(E) | 11.01.2023 |
129 | Clozapine | Tablet 25mg | 1 Tablet | 2.78 | 87(E) | 06.01.2023 |
130 | Clozapine | Tablet 50mg | 1 Tablet | 5.19 | 87(E) | 06.01.2023 |
131 | Clozapine | Tablet 100 mg | 1 Tablet | 8.45 | 87(E) | 06.01.2023 |
132 | Colchicine | Tablet 0.5mg | 1 Tablet | 3.26 | 484(E) | 02.02.2023 |
133 | Cyclophosphami de | Powder for Injection 500mg | 1 Vial | 73.48 | 194(E) | 11.01.2023 |
134 | Cycloserine | Capsule250mg | 1 Capsule | 59.18 | 5938(E) | 19.12.2022 |
135 | Cyclosporine | Capsule 25 mg | 1 Capsule | 28.04 | 194(E) | 11.01.2023 |
136 | Cyclosporine | Oral liquid 100mg/mL(p) | 1 ML | 80.58 | 194(E) | 11.01.2023 |
137 | Cyclosporine | Capsule 50 mg | 1 Capsule | 55.10 | 879(E) | 24.02.2023 |
138 | Cyclosporine | Capsule 100mg | 1 Capsule | 103.10 | 879(E) | 24.02.2023 |
139 | Cytosine arabinoside | Injection 1000mg/vial | 1 Vial | 1130.26 | 194(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
140 | Cytosine arabinoside | Injection 100mg/vial | 1 Vial | 139.58 | 484(E) | 02.02.2023 |
141 | Cytosine arabinoside | Injection 500mg/vial | 1 Vial | 536.30 | 484(E) | 02.02.2023 |
142 | Dacarbazine | Powder for Injection 200mg | 1 Vial | 381.72 | 87(E) | 06.01.2023 |
143 | Dacarbazine | Powder for Injection 500mg | 1 Vial | 518.79 | 194(E) | 11.01.2023 |
144 | Daclatasvir | Tablet 60mg | 1 Tablet | 199.95 | 5939(E) | 19.12.2022 |
145 | Darunavir | Tablet 600mg | 1 Tablet | 154.42 | 5938(E) | 19.12.2022 |
146 | Dexamethasone | Tablet 0.5mg | 1 Tablet | 0.22 | 484(E) | 02.02.2023 |
147 | Diazepam | Tablet 5 mg | 1 Tablet | 1.62 | 194(E) | 11.01.2023 |
148 | Diazepam | Injection 5mg/mL | 1 ML | 5.53 | 194(E) | 11.01.2023 |
149 | Diclofenac | Tablet 50mg | 1 Tablet | 2.05 | 87(E) | 06.01.2023 |
150 | Diclofenac | Injection 25mg/mL | 1 ML | 1.69 | 194(E) | 11.01.2023 |
151 | Diethylcarbamaz ine (DEC) | Tablet 100mg | 1 Tablet | 1.67 | 5938(E) | 19.12.2022 |
152 | Diethylcarbamaz ine (DEC) | Tablet 50mg | 1 Tablet | 0.56 | 879(E) | 24.02.2023 |
153 | Diethylcarbamaz ine (DEC) | Oral liquid 120mg/5mL(p) | 1 ML | 0.48 | 879(E) | 24.02.2023 |
154 | Digoxin | Tablet 0.25mg | 1 Tablet | 1.33 | 87(E) | 06.01.2023 |
155 | Diltiazem | Tablet 60mg | 1 Tablet | 5.46 | 87(E) | 06.01.2023 |
156 | Dinoprostone | Gel 0.5mg | 1 GM | 84.71 | 879(E) | 24.02.2023 |
157 | Docetaxel | Powder for Injection 20mg | 1 Vial | 2868.23 | 87(E) | 06.01.2023 |
158 | Docetaxel | Powder for Injection 80mg | 1 Vial | 10333.12 | 194(E) | 11.01.2023 |
159 | Dolutegravir | Tablet 50mg | 1 Tablet | 112.78 | 5939(E) | 19.12.2022 |
160 | Domperidone | Tablet 10mg | 1 Tablet | 2.30 | 183(E) | 11.01.2023 |
161 | Domperidone | Oral Liquid 1mg/mL | 1 ML | 1.24 | 194(E) | 11.01.2023 |
162 | Donepezil | Tablet 10mg | 1 Tablet | 17.45 | 89(E) | 06.01.2023 |
163 | Donepezil | Tablet 5mg | 1 Tablet | 12.10 | 89(E) | 06.01.2023 |
164 | Dopamine | Injection 40mg/mL | 1 ML | 4.76 | 194(E) | 11.01.2023 |
165 | Doxycycline | Capsule 100mg | 1 Capsule | 3.08 | 484(E) | 02.02.2023 |
166 | D-Penicillamine | Capsule 250 mg | 1 Capsule | 15.65 | 194(E) | 11.01.2023 |
167 | Efavirenz | Tablet 600mg | 1 Tablet | 70.59 | 194(E) | 11.01.2023 |
168 | Enalapril | Tablet 5mg | 1 Tablet | 3.70 | 87(E) | 06.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
169 | Enalapril | Tablet 2.5mg | 1 Tablet | 2.18 | 87(E) | 06.01.2023 |
170 | Entecavir | Tablet 1mg | 1 Tablet | 130.22 | 5938(E) | 19.12.2022 |
171 | Entecavir | Tablet 0.5mg | 1 Tablet | 84.43 | 195(E) | 11.01.2023 |
172 | Erythropoietin | Injection 2000IU/mL | 1 ML | 549.55 | 879(E) | 24.02.2023 |
173 | Erythropoietin | Injection 10000 IU/mL | 1 ML | 1969.00 | 879(E) | 24.02.2023 |
174 | Escitalopram | Tablet 5mg | 1 Tablet | 5.02 | 87(E) | 06.01.2023 |
175 | Escitalopram | Tablet 10mg | 1 Tablet | 9.00 | 87(E) | 06.01.2023 |
176 | Escitalopram | Tablet 20mg | 1 Tablet | 14.36 | 87(E) | 06.01.2023 |
177 | Ethambutol | Tablet 600mg | 1 Tablet | 4.08 | 87(E) | 06.01.2023 |
178 | Ethambutol | Tablet 800mg | 1 Tablet | 4.95 | 87(E) | 06.01.2023 |
179 | Ethambutol | Tablet 400mg | 1 Tablet | 2.61 | 87(E) | 06.01.2023 |
180 | Ethinylestradiol (A)+ Levonorgestrel (B) | Tablet 0.03mg(A) + Tablet 0.15mg(B) | 1 Tablet | 3.17 | 87(E) | 06.01.2023 |
181 | Ethionamide | Tablet 250mg | 1 Tablet | 14.81 | 5938(E) | 19.12.2022 |
182 | Etoposide | Capsule 50mg | 1 Capsule | 56.63 | 194(E) | 11.01.2023 |
183 | Etoposide | Injection 20mg/mL | 1 ML | 34.51 | 194(E) | 11.01.2023 |
184 | Filgrastim | Injection 300mcg | 1 Vial | 1159.91 | 879(E) | 24.02.2023 |
185 | Fluconazole | Tablet 400mg | 1 Tablet | 29.74 | 5938(E) | 19.12.2022 |
186 | Fluconazole | Tablet 200mg | 1 Tablet | 17.45 | 87(E) | 06.01.2023 |
187 | Fluconazole | Tablet 100mg | 1 Tablet | 7.62 | 87(E) | 06.01.2023 |
188 | Fluconazole | Tablet 150mg | 1 Tablet | 12.06 | 194(E) | 11.01.2023 |
189 | Fluconazole | Tablet 50mg | 1 Tablet | 9.67 | 485(E) | 02.02.2023 |
190 | Flunarizine | Tablet 5mg | 1 Tablet | 2.47 | 5938(E) | 19.12.2022 |
191 | Flunarizine | Tablet 10mg | 1 Tablet | 4.82 | 5938(E) | 19.12.2022 |
192 | Fluoxetine | Capsule 20 mg | 1 Capsule | 3.99 | 5938(E) | 19.12.2022 |
193 | Fluoxetine | Capsule 60 mg | 1 Capsule | 11.10 | 5938(E) | 19.12.2022 |
194 | Fluoxetine | Capsule 40 mg | 1 Capsule | 6.49 | 5938(E) | 19.12.2022 |
195 | Fluoxetine | Capsule 10 mg | 1 Capsule | 3.31 | 5938(E) | 19.12.2022 |
196 | Fluphenazine | Injection 25mg/mL | 1 ML | 55.26 | 879(E) | 24.02.2023 |
197 | Folic Acid | Tablet 5 mg | 1 Tablet | 1.51 | 194(E) | 11.01.2023 |
198 | Furosemide | Tablet 40mg | 1 Tablet | 0.90 | 484(E) | 02.02.2023 |
199 | Furosemide | Injection 10mg/mL | 1 ML | 2.99 | 879(E) | 24.02.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
200 | Fusidic acid | Cream 2 % | 1 GM | 9.83 | 879(E) | 24.02.2023 |
201 | Gefitinib | Tablet 250mg | 1 Tablet | 237.12 | 484(E) | 02.02.2023 |
202 | Gemcitabine | Powder for Injection 1000mg | 1 Vial | 5592.24 | 87(E) | 06.01.2023 |
203 | Gemcitabine | Powder for Injection 200 mg | 1 Vial | 1299.72 | 87(E) | 06.01.2023 |
204 | Gentamicin | Injection 10mg/mL | 1 ML | 2.41 | 879(E) | 24.02.2023 |
205 | Glimepiride | Tablet 2mg | 1 Tablet | 5.79 | 89(E) | 06.01.2023 |
206 | Glimepiride | Tablet 1mg | 1 Tablet | 3.70 | 89(E) | 06.01.2023 |
207 | Glucose | Injection 25% | 1 ML | 0.20 | 879(E) | 24.02.2023 |
208 | Glyceryl trinitrate | Injection 5mg/mL | 1 ML | 6.18 | 194(E) | 11.01.2023 |
209 | Glycopyrrolate | Injection 0.2mg/mL | 1 ML | 14.53 | 194(E) | 11.01.2023 |
210 | Griseofulvin | Tablet 250mg | 1 Tablet | 1.77 | 87(E) | 06.01.2023 |
211 | Haloperidol | Tablet 1.5mg | 1 Tablet | 1.56 | 89(E) | 06.01.2023 |
212 | Haloperidol | Tablet 5mg | 1 Tablet | 3.56 | 5938(E) | 19.12.2022 |
213 | Haloperidol | Tablet 10mg | 1 Tablet | 4.77 | 5938(E) | 19.12.2022 |
214 | Haloperidol | Oral liquid 2mg/5mL | 1 ML | 2.24 | 194(E) | 11.01.2023 |
215 | Halothane | Liquid for inhalation | 1 ML | 6.09 | 879(E) | 24.02.2023 |
216 | Heparin | Injection 1000IU/mL | 1 ML | 21.21 | 5938(E) | 19.12.2022 |
217 | Heparin | Injection 5000IU/mL | 1 ML | 59.96 | 5938(E) | 19.12.2022 |
218 | Homatropine | Drops 2% | 1 ML | 6.40 | 484(E) | 02.02.2023 |
219 | Hormone Releasing IUD | Contains 52 mg of Levonorgestrel | 1 IUD | 4103.29 | 1520(E) | 29.03.2023 |
220 | Human chorionic gonadotropin | Injection 5000 IU | 1 Vial | 417.45 | 879(E) | 24.02.2023 |
221 | Hydrochlorothiaz ide | Tablet 25 mg | 1 Tablet | 1.74 | 194(E) | 11.01.2023 |
222 | Hydrochlorothiaz ide | Tablet 12.5mg | 1 Tablet | 1.04 | 194(E) | 11.01.2023 |
223 | Hydrocortisone | Powder for Injection 100mg | 1 Vial | 44.79 | 87(E) | 06.01.2023 |
224 | Hydrocortisone | Tablet 10mg | 1 Tablet | 6.70 | 879(E) | 24.02.2023 |
225 | Hydrocortisone | Powder for Injection 200mg | 1 Vial | 65.60 | 879(E) | 24.02.2023 |
226 | Hydrocortisone | Tablet 5mg | 1 Tablet | 3.11 | 879(E) | 24.02.2023 |
227 | Hydrocortisone | Tablet 20mg | 1 Tablet | 14.88 | 880(E) | 24.02.2023 |
228 | Hydroxy propylmethyl cellulose | Injection 2% | 1 ML | 29.20 | 879(E) | 24.02.2023 |
229 | Hydroxychloroqu | Tablet 400mg | 1 Tablet | 13.80 | 5938(E) | 19.12.2022 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
ine | ||||||
230 | Hydroxychloroqu ine | Tablet 200mg | 1 Tablet | 6.35 | 87(E) | 06.01.2023 |
231 | Hydroxyurea | Capsule 500mg | 1 Capsule | 12.12 | 87(E) | 06.01.2023 |
232 | Ibuprofen | Tablet 200mg | 1 Tablet | 0.70 | 87(E) | 06.01.2023 |
233 | Ibuprofen | Tablet 400mg | 1 Tablet | 1.19 | 194(E) | 11.01.2023 |
234 | Ibuprofen | Oral liquid 100mg/5mL(p) | 1 ML | 0.22 | 484(E) | 02.02.2023 |
235 | Imatinib | Tablet 100mg | 1 Tablet | 69.75 | 87(E) | 06.01.2023 |
236 | Imatinib | Tablet 400mg | 1 Tablet | 199.61 | 194(E) | 11.01.2023 |
237 | Insulin Intermediate Acting (NPH) | Injection 40IU/mL | 1 ML | 16.98 | 879(E) | 24.02.2023 |
238 | Iron sucrose | Injection 20mg/mL | 1 ML | 57.40 | 879(E) | 24.02.2023 |
239 | Isoflurane | Liquid for inhalation | 1 ML | 9.65 | 194(E) | 11.01.2023 |
240 | Isosorbide dinitrate | Tablet 5mg | 1 Tablet | 0.81 | 5938(E) | 19.12.2022 |
241 | Isosorbide dinitrate | Tablet 10mg | 1 Tablet | 0.80 | 879(E) | 24.02.2023 |
242 | Ispaghula | Granules/Husk/Pow der | 1 GM | 0.94 | 879(E) | 24.02.2023 |
243 | Itraconazole | Oralliquid 10mg/mL | 1 ML | 4.94 | 5939(E) | 19.12.2022 |
244 | IUD containing Copper | As licensed | 1 IUD | 280.99 | 879(E) | 24.02.2023 |
245 | Ketamine | Injection 50mg/mL | 1 ML | 12.12 | 484(E) | 02.02.2023 |
246 | Labetalol | Injection 5mg/mL | 1 ML | 49.98 | 194(E) | 11.01.2023 |
247 | Lactulose | Oral liquid 10 g/15mL | 1 ML | 1.23 | 194(E) | 11.01.2023 |
248 | Lamivudine | Tablet 100mg | 1 Tablet | 10.40 | 5939(E) | 19.12.2022 |
249 | Lamivudine | Tablet 150mg | 1 Tablet | 10.86 | 5939(E) | 19.12.2022 |
250 | L-Asparaginase | Powder for Injection 5000 KU | 1 Vial | 1034.81 | 87(E) | 06.01.2023 |
251 | L-Asparaginase | Powder for Injection 10000KU | 1 Vial | 1707.64 | 87(E) | 06.01.2023 |
252 | Lenalidomide | Capsule 5mg | 1 Capsule | 67.25 | 5939(E) | 19.12.2022 |
253 | Lenalidomide | Capsule 25 mg | 1 Capsule | 292.25 | 195(E) | 11.01.2023 |
254 | Letrozole | Tablet 2.5mg | 1 Tablet | 29.31 | 5938(E) | 19.12.2022 |
255 | Leuprolide | Powder for injection | 1 Vial | 17080.55 | 195(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
acetate | 22.5 mg | |||||
256 | Leuprolide acetate | Powder for injection 11.25mg | 1 Vial | 9293.96 | 195(E) | 11.01.2023 |
257 | Leuprolide acetate | Powder for injection 3.75 mg | 1 Vial | 3112.50 | 195(E) | 11.01.2023 |
258 | Levetiracetam | Tablet 250mg | 1 Tablet | 6.30 | 89(E) | 06.01.2023 |
259 | Levetiracetam | Tablet 500mg | 1 Tablet | 12.98 | 89(E) | 06.01.2023 |
260 | Levetiracetam | Modified Release Tablet 750mg | 1 Tablet | 18.29 | 5938(E) | 19.12.2022 |
261 | Levetiracetam | Tablet 750mg | 1 Tablet | 19.34 | 89(E) | 06.01.2023 |
262 | Levetiracetam | Oral liquid 100 mg/mL (p) | 1 ML | 3.96 | 194(E) | 11.01.2023 |
263 | Levetiracetam | Injection 100mg/mL | 1 ML | 23.01 | 484(E) | 02.02.2023 |
264 | Levodopa (A) + Carbidopa (B) | Modified Release– Tablet 200mg (A) + 50mg (B) | 1 Tablet | 4.73 | 194(E) | 11.01.2023 |
265 | Levodopa (A) +Carbidopa(B) | Tablet 100 mg (A) + 25 mg (B) | 1 Tablet | 2.57 | 5938(E) | 19.12.2022 |
266 | Levodopa (A) +Carbidopa(B) | Tablet 100 mg (A) + 10 mg (B) | 1 Tablet | 1.76 | 5938(E) | 19.12.2022 |
267 | Levodopa (A) +Carbidopa(B) | Tablet 250mg(A) +25mg(B) | 1 Tablet | 4.41 | 5938(E) | 19.12.2022 |
268 | Levodopa (A) +Carbidopa(B) | Modified Release– Tablet 100 mg (A) + 25 mg (B) | 1 Tablet | 2.79 | 879(E) | 24.02.2023 |
269 | Levofloxacin | Tablet 250mg | 1 Tablet | 4.76 | 89(E) | 06.01.2023 |
270 | Levofloxacin | Tablet 500mg | 1 Tablet | 8.80 | 89(E) | 06.01.2023 |
271 | Levofloxacin | Tablet 750mg | 1 Tablet | 12.44 | 89(E) | 06.01.2023 |
272 | Levothyroxine | Tablet 50mcg | 1 Tablet | 1.03 | 5938(E) | 19.12.2022 |
273 | Levothyroxine | Tablet 75mcg | 1 Tablet | 1.43 | 5938(E) | 19.12.2022 |
274 | Levothyroxine | Tablet 88 mcg | 1 Tablet | 1.64 | 5938(E) | 19.12.2022 |
275 | Levothyroxine | Tablet 112 mcg | 1 Tablet | 1.65 | 5938(E) | 19.12.2022 |
276 | Levothyroxine | Tablet 25 mcg | 1 Tablet | 1.44 | 5938(E) | 19.12.2022 |
277 | Levothyroxine | Tablet 62.5mcg | 1 Tablet | 1.61 | 194(E) | 11.01.2023 |
278 | Levothyroxine | Tablet 12.5mcg | 1 Tablet | 1.48 | 879(E) | 24.02.2023 |
279 | Levothyroxine | Tablet 100mcg | 1 Tablet | 1.32 | 879(E) | 24.02.2023 |
280 | Levothyroxine | Tablet 125mcg | 1 Tablet | 1.69 | 879(E) | 24.02.2023 |
281 | Lignocaine | Topical forms 2-5 % | 1 GM/ML | 1.13 | 879(E) | 24.02.2023 |
282 | Lignocaine | Injection 2% | 1 ML | 1.04 | 879(E) | 24.02.2023 |
283 | Linezolid | Tablet 600mg | 1 Tablet | 35.66 | 5938(E) | 19.12.2022 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
284 | Lithium | Tablet 300mg | 1 Tablet | 1.62 | 194(E) | 11.01.2023 |
285 | Loperamide | Tablet 2mg | 1 Tablet | 2.27 | 5938(E) | 19.12.2022 |
286 | Lopinavir (A) + Ritonavir(B) | Tablet 200 mg (A) + 50mg (B) | 1 Tablet | 47.96 | 194(E) | 11.01.2023 |
287 | Lorazepam | Tablet 1 mg | 1 Tablet | 2.30 | 5938(E) | 19.12.2022 |
288 | Lorazepam | Tablet 2 mg | 1 Tablet | 2.81 | 5938(E) | 19.12.2022 |
289 | Magnesium sulphate | Injection 500mg/mL | 1 ML | 4.86 | 879(E) | 24.02.2023 |
290 | Mannitol | Injection 20 % | 1 ML | 0.34 | 194(E) | 11.01.2023 |
291 | Mebendazole | Tablet 100 mg | 1 Tablet | 2.90 | 5938(E) | 19.12.2022 |
292 | Mebendazole | Oral liquid 100mg/5mL(p) | 1 ML | 0.84 | 194(E) | 11.01.2023 |
293 | Medroxyprogest erone acetate | Tablet 10 mg | 1 Tablet | 6.24 | 194(E) | 11.01.2023 |
294 | Medroxyprogest erone acetate | Injection 150mg/mL | 1 ML | 289.74 | 195(E) | 11.01.2023 |
295 | Mefenamicacid | Oral liquid 100mg/5mL(p) | 1 ML | 0.56 | 5938(E) | 19.12.2022 |
296 | Mefloquine | Tablet 250 mg | 1 Tablet | 52.15 | 87(E) | 06.01.2023 |
297 | Meglumine diatrizoate | Injection 60%w/v | 1 ML | 9.47 | 879(E) | 24.02.2023 |
298 | Meglumine diatrizoate | Injection 76%w/v | 1 ML | 10.20 | 879(E) | 24.02.2023 |
299 | Mesna | Injection 100mg/mL | 1 ML | 15.50 | 5938(E) | 19.12.2022 |
300 | Metformin | Tablet 1000mg | 1 Tablet | 3.48 | 5938(E) | 19.12.2022 |
301 | Metformin | Tablet 500mg | 1 Tablet | 2.01 | 89(E) | 06.01.2023 |
302 | Metformin | Modified release Tablet 1000mg | 1 Tablet | 4.04 | 89(E) | 06.01.2023 |
303 | Methotrexate | Tablet 10mg | 1 tablet | 13.28 | 87(E) | 06.01.2023 |
304 | Methotrexate | Tablet 2.5mg | 1 tablet | 5.31 | 87(E) | 06.01.2023 |
305 | Methylergometri ne | Tablet 0.125mg | 1 Tablet | 8.93 | 194(E) | 11.01.2023 |
306 | Methylergometri ne | Injection 0.2mg/mL | 1 ML | 14.94 | 484(E) | 02.02.2023 |
307 | Metoclopramide | Tablet 10mg | 1 Tablet | 1.34 | 87(E) | 06.01.2023 |
308 | Metoclopramide | Injection 5mg/mL (Less than 10ML Pack) | 1 ML | 2.66 | 879(E) | 24.02.2023 |
309 | Metoprolol | Tablet 25mg | 1 Tablet | 4.20 | 87(E) | 06.01.2023 |
310 | Metoprolol | Tablet 50mg | 1 Tablet | 5.84 | 87(E) | 06.01.2023 |
311 | Metoprolol | Modified Release | 1 Tablet | 14.99 | 195(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
Tablet 100 mg | ||||||
312 | Metoprolol | Tablet 100 mg | 1 Tablet | 11.13 | 195(E) | 11.01.2023 |
313 | Metronidazole | Tablet 200mg | 1 Tablet | 0.81 | 87(E) | 06.01.2023 |
314 | Metronidazole | Tablet 400mg | 1 Tablet | 1.52 | 87(E) | 06.01.2023 |
315 | Metronidazole | Injection 500mg/100mL | 1 ML | 0.21 | 194(E) | 11.01.2023 |
316 | Metronidazole | Oral liquid 200mg/5mL(p) | 1 ML | 0.51 | 194(E) | 11.01.2023 |
317 | Midazolam | Nasal Spray 1.25mg/ actuation | 1 ML | 216.80 | 195(E) | 11.01.2023 |
318 | Midazolam | Nasal Spray 0.5 mg/actuation | 1 ML | 79.93 | 195(E) | 11.01.2023 |
319 | Midazolam | Injection 1mg/mL | 1 ML | 5.92 | 879(E) | 24.02.2023 |
320 | Midazolam | Injection 5mg/mL | 1 ML | 10.87 | 879(E) | 24.02.2023 |
321 | Mifepristone | Tablet 200mg | 1 Tablet | 350.89 | 194(E) | 11.01.2023 |
322 | Misoprostol | Tablet 200mcg | 1 Tablet | 18.97 | 5938(E) | 19.12.2022 |
323 | Misoprostol | Tablet 100mcg | 1 Tablet | 9.92 | 194(E) | 11.01.2023 |
324 | Montelukast | Tablet 4 mg | 1 Tablet | 10.03 | 5939(E) | 19.12.2022 |
325 | Montelukast | Tablet 5 mg (including chewable Tablet s) | 1 Tablet | 11.71 | 5939(E) | 19.12.2022 |
326 | Montelukast | Tablet 10 mg | 1 Tablet | 16.43 | 5939(E) | 19.12.2022 |
327 | Morphine | Injection 10mg/mL | 1 ML | 19.59 | 879(E) | 24.02.2023 |
328 | Morphine | Injection 15mg/mL | 1 ML | 14.93 | 879(E) | 24.02.2023 |
329 | Moxifloxacin | Tablet 400mg | 1 Tablet | 25.82 | 89(E) | 06.01.2023 |
330 | Mycophenolate mofetil | Tablet 500mg | 1 Tablet | 73.87 | 5938(E) | 19.12.2022 |
331 | Mycophenolate mofetil | Tablet 250mg | 1 Tablet | 49.60 | 484(E) | 02.02.2023 |
332 | N-acetylcysteine | Injection 200 mg/mL | 1 ML | 23.63 | 194(E) | 11.01.2023 |
333 | Naloxone | Injection 0.4mg/mL | 1 ML | 92.72 | 194(E) | 11.01.2023 |
334 | Natamycin | Drops 5% | 1 ML | 23.37 | 484(E) | 02.02.2023 |
335 | Neostigmine | Injection 0.5mg/mL | 1 ML | 5.01 | 194(E) | 11.01.2023 |
336 | Neostigmine | Tablet 15mg | 1 Tablet | 4.58 | 879(E) | 24.02.2023 |
337 | Nevirapine | Tablet 200 mg | 1 Tablet | 15.79 | 5938(E) | 19.12.2022 |
338 | Nifedipine | Tablet 10mg | 1 Tablet | 1.53 | 879(E) | 24.02.2023 |
339 | Nitrofurantoin | Tablet 100 mg | 1 Tablet | 8.10 | 87(E) | 06.01.2023 |
340 | Noradrenaline | Injection 2mg/mL | 1 ML | 20.17 | 879(E) | 24.02.2023 |
341 | Norethisterone | Tablet 5mg | 1 Tablet | 5.39 | 87(E) | 06.01.2023 |
342 | Omeprazole | Capsule 20 mg | 1 | 2.87 | 484(E) | 02.02.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
Capsule | ||||||
343 | Ondansetron | Tablet 4 mg | 1 Tablet | 5.13 | 194(E) | 11.01.2023 |
344 | Ondansetron | Oral liquid 2mg/5mL(p) | 1 ML | 1.25 | 194(E) | 11.01.2023 |
345 | Ondansetron | Injection 2mg/mL | 1 ML | 5.96 | 484(E) | 02.02.2023 |
346 | Oxaliplatin | Injection 5 mg/mL in 10 mL vial | 1 Vial | 2233.82 | 194(E) | 11.01.2023 |
347 | Oxytocin | Injection 5 IU/mL | 1 ML | 17.83 | 484(E) | 02.02.2023 |
348 | Pantoprazole | Injection 40mg | 1 Vial | 50.45 | 87(E) | 06.01.2023 |
349 | Paracetamol | Tablet 650mg | 1 Tablet | 2.00 | 89(E) | 06.01.2023 |
350 | Paracetamol | Oral Liquid 125 mg/5 mL (p) | 1 ML | 0.37 | 194(E) | 11.01.2023 |
351 | Paracetamol | Oral Liquid 250 mg/5 mL (p) | 1 ML | 0.67 | 194(E) | 11.01.2023 |
352 | Paracetamol | Oral liquid 120 mg/5 mL (p) | 1 ML | 0.60 | 194(E) | 11.01.2023 |
353 | Paracetamol | Tablet 500mg | 1 Tablet | 0.89 | 484(E) | 02.02.2023 |
354 | Paracetamol | Suppository 80mg | 1 Supposit ory | 6.66 | 484(E) | 02.02.2023 |
355 | Paracetamol | Suppository 170mg | 1 Supposit ory | 7.94 | 484(E) | 02.02.2023 |
356 | Phenobarbitone | Tablet 30mg | 1 Tablet | 1.31 | 87(E) | 06.01.2023 |
357 | Phenobarbitone | Tablet 60mg | 1 Tablet | 1.89 | 194(E) | 11.01.2023 |
358 | Phenobarbitone | Injection 200mg/mL | 1 ML | 22.14 | 194(E) | 11.01.2023 |
359 | Phenobarbitone | Oral liquid 20mg/5mL (p) | 1 ML | 0.49 | 879(E) | 24.02.2023 |
360 | Phenytoin | Tablet 300mg | 1 Tablet | 5.48 | 87(E) | 06.01.2023 |
361 | Phenytoin | Injection 50mg/mL | 1 ML | 5.95 | 194(E) | 11.01.2023 |
362 | Phytomenadione (Vitamin K1) | Injection 10mg/mL | 1 ML | 53.08 | 879(E) | 24.02.2023 |
363 | Pilocarpine | Drops 2 % | 1 ML | 10.83 | 879(E) | 24.02.2023 |
364 | Piperacillin (A) +Tazobactam(B) | Powder for Injection 1000mg(A)+125mg( B) | 1 Vial | 99.65 | 87(E) | 06.01.2023 |
365 | Piperacillin (A) +Tazobactam(B) | Powder for Injection 2000mg(A)+250mg( B) | 1 Vial | 191.53 | 87(E) | 06.01.2023 |
366 | Piperacillin (A) +Tazobactam(B) | Powder for Injection 4000mg(A)+500mg( | 1 Vial | 399.38 | 87(E) | 06.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
B) | ||||||
367 | Potassium chloride | Oral liquid 500mg/5mL | 1 ML | 0.30 | 194(E) | 11.01.2023 |
368 | Potassium chloride | Injection 150mg/mL | 1 ML | 2.39 | 879(E) | 24.02.2023 |
369 | Povidone iodine | Solution 5% | 1 ML | 0.43 | 879(E) | 24.02.2023 |
370 | Povidone iodine | Solution 7.5% | 1 ML | 0.81 | 879(E) | 24.02.2023 |
371 | Povidone iodine | Solution 10% ( | 1 ML | 0.96 | 879(E) | 24.02.2023 |
372 | Pralidoxime chloride (2-PAM) | Injection 25mg/mL | 1 ML | 4.56 | 194(E) | 11.01.2023 |
373 | Prednisolone | Tablet 40mg | 1 Tablet | 3.40 | 194(E) | 11.01.2023 |
374 | Prednisolone | Oral liquid 5mg/5mL(p) | 1 ML | 0.49 | 194(E) | 11.01.2023 |
375 | Prednisolone | Oral liquid 15mg/5mL(p) | 1 ML | 0.86 | 194(E) | 11.01.2023 |
376 | Prednisolone | Tablet 10mg | 1 Tablet | 1.19 | 484(E) | 02.02.2023 |
377 | Prednisolone | Tablet 5mg | 1 Tablet | 0.68 | 484(E) | 02.02.2023 |
378 | Prednisolone | Tablet 20mg | 1 Tablet | 2.39 | 484(E) | 02.02.2023 |
379 | Prednisolone | Drops 1% | 1 ML | 5.76 | 879(E) | 24.02.2023 |
380 | Primaquine | Tablet 7.5mg | 1 Tablet | 2.37 | 87(E) | 06.01.2023 |
381 | Primaquine | Tablet 15mg | 1 Tablet | 5.13 | 484(E) | 02.02.2023 |
382 | Proparacaine | Eye Drops0.5% | 1 ML | 10.24 | 194(E) | 11.01.2023 |
383 | Propofol | Injection 10mg/mL | 1 ML | 6.50 | 879(E) | 24.02.2023 |
384 | Propranolol | Tablet 40mg | 1 Tablet | 3.21 | 87(E) | 06.01.2023 |
385 | Propranolol | Tablet 10mg | 1 Tablet | 1.31 | 87(E) | 06.01.2023 |
386 | Propranolol | Tablet 20mg | 1 Tablet | 3.19 | 195(E) | 11.01.2023 |
387 | Protamine Sulphate | Injection 10mg/mL | 1 ML | 9.77 | 879(E) | 24.02.2023 |
388 | Pyrazinamide | Tablet 1000mg | 1 Tablet | 10.52 | 87(E) | 06.01.2023 |
389 | Pyrazinamide | Tablet 500mg | 1 Tablet | 4.88 | 87(E) | 06.01.2023 |
390 | Pyrazinamide | Tablet 750mg | 1 Tablet | 7.20 | 87(E) | 06.01.2023 |
391 | Pyrazinamide | Tablet 1500mg | 1 Tablet | 11.80 | 879(E) | 24.02.2023 |
392 | Pyridoxine | Tablet 100 mg | 1 Tablet | 5.97 | 484(E) | 02.02.2023 |
393 | Quinine | Tablet 300 mg | 1 Tablet | 5.65 | 87(E) | 06.01.2023 |
394 | Rabies vaccine | As licensed | 1 Vial | 378.69 | 879(E) | 24.02.2023 |
395 | Raltegravir | Tablet 400mg | 1 Tablet | 147.78 | 5938(E) | 19.12.2022 |
396 | Ramipril | Tablet 2.5 mg | 1 Tablet | 5.21 | 5938(E) | 19.12.2022 |
397 | Ramipril | Tablet 5mg | 1 Tablet | 8.18 | 5938(E) | 19.12.2022 |
398 | Ribavirin | Capsule 200 mg | 1 Capsule | 26.49 | 194(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
399 | Rifampicin | Capsule 600mg | 1 Capsule | 11.35 | 5938(E) | 19.12.2022 |
400 | Rifampicin | Capsule 450mg | 1 Capsule | 5.67 | 87(E) | 06.01.2023 |
401 | Rifampicin | Capsule 150mg | 1 Capsule | 2.28 | 194(E) | 11.01.2023 |
402 | Rifampicin | Capsule 300mg | 1 Capsule | 4.60 | 194(E) | 11.01.2023 |
403 | Rifampicin | Oral liquid 100mg/5mL(p) | 1 ML | 0.47 | 879(E) | 24.02.2023 |
404 | Risperidone | Tablet 1 mg | 1 Tablet | 3.02 | 89(E) | 06.01.2023 |
405 | Risperidone | Tablet 2 mg | 1 Tablet | 4.48 | 5938(E) | 19.12.2022 |
406 | Risperidone | Tablet 4 mg | 1 Tablet | 7.35 | 5938(E) | 19.12.2022 |
407 | Risperidone | Oral liquid 1mg/mL | 1 ML | 2.20 | 194(E) | 11.01.2023 |
408 | Ritonavir | Tablet 100mg | 1 Tablet | 29.20 | 484(E) | 02.02.2023 |
409 | Rituximab | Injection 10mg/mL | 1 ML | 761.76 | 484(E) | 02.02.2023 |
410 | Salbutamol | Tablet 4 mg | 1 Tablet | 0.21 | 87(E) | 06.01.2023 |
411 | Salbutamol | Tablet 2 mg | 1 Tablet | 0.17 | 87(E) | 06.01.2023 |
412 | Salbutamol | Oral liquid 2mg/5mL | 1 ML | 0.17 | 194(E) | 11.01.2023 |
413 | Salbutamol | Inhalation (MDI/DPI) 100mcg/dose | 1 Dose | 0.49 | 484(E) | 02.02.2023 |
414 | Salbutamol | Respirator Solution (Solution for Nebulizer 5mg/mL) | 1 ML | 0.68 | 484(E) | 02.02.2023 |
415 | Salicylic acid | Ointment 3-6% (6%) | 1 GM | 2.01 | 879(E) | 24.02.2023 |
416 | Sodium bicarbonate | Injection (as per IP) - 8.4% | 1 ML | 1.34 | 484(E) | 02.02.2023 |
417 | Sodium Valproate | Tablet 300mg | 1 Tablet | 4.46 | 5938(E) | 19.12.2022 |
418 | Sodium Valproate | Oral liquid 200mg/5mL(p) | 1 ML | 0.65 | 484(E) | 02.02.2023 |
419 | Sodium Valproate | Tablet 200mg | 1 Tablet | 3.58 | 879(E) | 24.02.2023 |
420 | Sodium Valproate | Modified Release – Tablet 500mg | 1 Tablet | 9.28 | 879(E) | 24.02.2023 |
421 | Sodium Valproate | Tablet 500mg | 1 Tablet | 8.11 | 879(E) | 24.02.2023 |
422 | Sodium Valproate | Modified Release – Tablet 300mg | 1 Tablet | 6.09 | 879(E) | 24.02.2023 |
423 | Sodium Valproate | Injection 100mg/mL | 1 ML | 6.74 | 879(E) | 24.02.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
424 | Sofosbuvir | Tablet 400mg | 1 Tablet | 525.08 | 5938(E) | 19.12.2022 |
425 | Spironolactone | Tablet 50mg | 1 Tablet | 4.37 | 194(E) | 11.01.2023 |
426 | Spironolactone | Tablet 25mg | 1 Tablet | 2.18 | 484(E) | 02.02.2023 |
427 | Streptokinase | Injection 15,00,000IU | 1 Vial | 1877.23 | 194(E) | 11.01.2023 |
428 | Streptomycin | Powder for Injection 750 mg | 1 Vial | 10.10 | 194(E) | 11.01.2023 |
429 | Streptomycin | Powder for Injection 1000mg | 1 Vial | 10.86 | 194(E) | 11.01.2023 |
430 | Sulfasalazine | Tablet 500 mg | 1 Tablet | 4.72 | 87(E) | 06.01.2023 |
431 | Tacrolimus | Capsule 0.5mg | 1 Capusle | 20.66 | 5938(E) | 19.12.2022 |
432 | Tacrolimus | Capsule 1mg | 1 Capusle | 40.62 | 5938(E) | 19.12.2022 |
433 | Tacrolimus | Capsule 2mg | 1 Capusle | 84.33 | 5938(E) | 19.12.2022 |
434 | Tamoxifen | Tablet 20mg | 1 Tablet | 2.94 | 87(E) | 06.01.2023 |
435 | Tamoxifen | Tablet 10mg | 1 Tablet | 2.20 | 87(E) | 06.01.2023 |
436 | Telmisartan | Tablet 20mg | 1 Tablet | 3.87 | 89(E) | 06.01.2023 |
437 | Telmisartan | Tablet 40mg | 1 Tablet | 6.76 | 5938(E) | 19.12.2022 |
438 | Telmisartan | Tablet 80mg | 1 Tablet | 10.40 | 89(E) | 06.01.2023 |
439 | Temozolomide | Capsule 20 mg | 1 Capsule | 441.31 | 5938(E) | 19.12.2022 |
440 | Temozolomide | Capsule 250mg | 1 Capsule | 4303.77 | 5938(E) | 19.12.2022 |
441 | Temozolomide | Capsule 100mg | 1 Capsule | 1508.62 | 194(E) | 11.01.2023 |
442 | Tenecteplase | Injection 40mg/vial | 1 Vial | 50386.90 | 195(E) | 11.01.2023 |
443 | Tenecteplase | Injection 30mg/vial | 1 Vial | 36907.98 | 195(E) | 11.01.2023 |
444 | Tenofovir Alafenamide Fumarate (TAF) | Tablet 25mg | 1 Tablet | 48.87 | 88(E) | 06.01.2023 |
445 | Tenofovir Disproxil Fumarate (A) + Lamivudine (B) | Tablet 300mg (A) + 300mg(B) | 1 Tablet | 45.57 | 194(E) | 11.01.2023 |
446 | Tenofovir Disproxil Fumarate (A) +Lamivudine (B)+ | Tablet 300mg(A)+ 300mg (B) + 600mg(C) | 1 Tablet | 102.83 | 194(E) | 11.01.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
Efavirenz(C) | ||||||
447 | Tenofovir Disproxil Fumarate (TDF)* | Tablet 300mg | 1 Tablet | 45.83 | 194(E) | 11.01.2023 |
448 | Thalidomide | Capsule 50 mg | 1 Capsule | 31.15 | 87(E) | 06.01.2023 |
449 | Thalidomide | Capsule 100mg | 1 Capsule | 62.01 | 87(E) | 06.01.2023 |
450 | Thiamine | Tablet 100 mg | 1 Tablet | 4.46 | 194(E) | 11.01.2023 |
451 | Thiamine | Injection 100 mg/mL | 1 ML | 22.59 | 879(E) | 24.02.2023 |
452 | Timolol | Drops 0.5 % | 1 ML | 13.39 | 194(E) | 11.01.2023 |
453 | Tiotropium | Inhalation (MDI) 9 mcg/dose | 1 MD | 2.78 | 879(E) | 24.02.2023 |
454 | Tiotropium | Inhalation (DPI) 18mcg/dose | 1 DP | 10.70 | 879(E) | 24.02.2023 |
455 | Tramadol | Injection 50mg/mL (upto 2ml pack) | 1 ML | 11.78 | 484(E) | 02.02.2023 |
456 | Tranexamic acid | Injection 100 mg/mL | 1 ML | 13.71 | 194(E) | 11.01.2023 |
457 | Tranexamic acid | Tablet 500 mg | 1 Tablet | 18.54 | 194(E) | 11.01.2023 |
458 | Trastuzumab | Injection 440mg/50mL | 1 Vial | 54722.18 | 194(E) | 11.01.2023 |
459 | Trihexyphenidyl | Tablet 2mg | 1 Tablet | 1.36 | 879(E) | 24.02.2023 |
460 | Tropicamide | Eye drop 1 % | 1 ML | 9.42 | 194(E) | 11.01.2023 |
461 | Valganciclovir | Tablet 450 mg | 1 Tablet | 400.71 | 5939(E) | 19.12.2022 |
462 | Vancomycin | Powder for Injection 500 mg | 1 Vial | 317.61 | 194(E) | 11.01.2023 |
463 | Vancomycin | Powder for Injection 1000mg | 1 Vial | 470.23 | 194(E) | 11.01.2023 |
464 | Vancomycin | Powder for Injection 250 mg | 1 Vial | 251.24 | 194(E) | 11.01.2023 |
465 | Vecuronium | Powder for injection 10mg | Each Vial | 117.35 | 5938(E) | 19.12.2022 |
466 | Vecuronium | Powder for injection 4 mg | Each Vial | 74.40 | 5938(E) | 19.12.2022 |
467 | Verapamil | Tablet 80 mg | 1 Tablet | 1.59 | 484(E) | 02.02.2023 |
468 | Verapamil | Tablet 40mg | 1 Tablet | 0.86 | 484(E) | 02.02.2023 |
469 | Vincristine | Injection 1mg/mL | 1 ML | 57.51 | 484(E) | 02.02.2023 |
470 | Xylometazoline | Nasal drops 0.05 % | 1 ML | 4.19 | 484(E) | 02.02.2023 |
471 | Xylometazoline | Nasal drops 0.1% | 1 ML | 5.12 | 484(E) | 02.02.2023 |
472 | Zidovudine (A) +Lamivudine (B) | Tablet 300mg (A) +150mg (B) + | 1 Tablet | 21.13 | 484(E) | 02.02.2023 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2023 with WPI @ 12.1218 %) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
+Nevirapine(C) | 200mg (c) | |||||
473 | Zidovudine (A) +Lamivudine(B) | Tablet 300mg (A)+ 150mg (B) | 1 Tablet | 21.09 | 87(E) | 06.01.2023 |
474 | Zoledronic acid | Powder for Injection 4mg | 1 Vial | 2391.91 | 194(E) | 11.01.2023 |
475 | Zolpidem | Tablet 5mg | 1 Tablet | 6.21 | 89(E) | 06.01.2023 |
476 | Zolpidem | Tablet 10mg | 1 Tablet | 8.51 | 5938(E) | 19.12.2022 |
Note:
Also Read:NPPA fixes ceiling Price of Levonorgestrel intrauterine device
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.